Inhibition of KDM4A activity as a strategy to suppress interleukin-6 production and attenuate colitis induction
Inhibition of KDM4A activity as a strategy to suppress interleukin-6 production and attenuate colitis induction
复制标题
DOI:
10.1016/j.clim.2017.05.014
复制
发表时间:
2017-07-01
影响因子:
8.6
通讯作者:
Hirooka, Yoshiki
中科院分区:
文献类型:
--
作者:
Ishiguro, Kazuhiro;Watanabe, Osamu;Hirooka, Yoshiki
4-Chloro-7-nitro-2,1,3-benzoxadiazole (NBD-CI) functions as a hapten and fluoresces upon binding to proteins. Therefore, fluorescence visualization of hapten-proteins is a feature of the colitis induced by NBD-Cl. Using this colitis model, we located activated fibroblasts in the vicinity of hapten-proteins upon colitis induction and observed interleukin (IL)-6 production in the activated fibroblasts. We screened herbal ingredients using primary fibroblasts stimulated with tumor necrosis factor alpha (TNF-alpha) and found the suppressive action of Atractylodin on IL-6 production. Under TNF-alpha stimulation, Atractylodin induced the tri-methylation of histone H3 at lysine residue 9, which impaired the binding between NF-kappa B and the IL-6 promoter on the genomic DNA. Atractylodin inhibited KDM4A but not KDM6A activity. Atractylodin administration attenuated colitis induction. The KDM4A inhibitor ML324 showed similar actions on IL-6 production and colitis induction. We propose the inhibition of KDM4A activity as a strategy to suppress IL-6 production and attenuate colitis induction. (C) 2017 Elsevier Inc. All rights reserved.